Hearing Loss Trial, Recruiting NCT04707885 Sponsor: Ohio State University Condition: Hearing Loss
Back to Hearing Loss

Hearing Loss Trial, Recruiting

NCT04707885
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 to 79 who have hearing loss in both ears, where the hearing loss developed after they had already learned to speak and understand language.
  • People who have worn properly fitted hearing aids in both ears for at least 30 days, with the fit verified using a standard measurement method.
  • People whose hearing aids provide limited benefit, shown by scoring at or below certain levels on standardised speech understanding tests in both ears (confirm with trial site for exact score thresholds).
  • People whose ear to be implanted has relatively better low-frequency (lower-pitched sound) hearing, but severe to profound loss in the mid-to-high frequency (higher-pitched sound) range.
  • People whose other ear also has relatively better low-frequency hearing, sloping to moderately severe or profound loss in the mid-to-high frequency range.
  • People who are fluent in English.
  • People who are receiving a cochlear implant from either Cochlear Limited (specific Nucleus models) or Advanced Bionics AG (specific HiFocus models).
  • People who are willing and able to attend all study visits and complete all required testing.

Who may not be able to join:

  • People who have previously received a cochlear implant.
  • People whose hearing loss began before they learned to speak and understand language.
  • People whose inner ear has an unusual structure, as seen on a CT scan.
  • People diagnosed with auditory neuropathy spectrum disorder, a specific type of hearing condition.
  • People with a hearing-related condition caused by a tumour on the hearing nerve (such as a vestibular schwannoma) or a stroke.
  • People who are unwilling or unable to follow all study requirements, including being randomly assigned to a treatment group.
  • People who have additional medical or personal circumstances that would prevent them from completing all study requirements.
  • People who have a medical condition that makes surgery unsafe for them.
  • People who have chosen a Med-El cochlear implant device.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Oliver Adunka, MD, Ohio State University

Phone: 614-366-9244

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ohio State University
Registry
ClinicalTrials.gov
Start date
10 November 2021
Est. completion
31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Preservation Advantage

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov